Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier

Journal of Drug Targeting

Volumn 22, Issue 10, 2014, Pages 891-900

  Yang, Yang ^a   Yang, Yanfang ^a   Xie, Xiangyang ^a,b   Cai, Xingshi ^a   Mei, Xingguo ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Cell penetrating peptides; Drug delivery; Nanostructured lipid carrier; Photo trigger

Indexed keywords

CELL PENETRATING PEPTIDE; LYSINE; NANOCARRIER; PACLITAXEL; ANTINEOPLASTIC AGENT; DRUG CARRIER; LIPID; NANOMATERIAL;

ARTICLE; CANCER CELL; CIRCULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENCAPSULATION; FIBROSARCOMA CELL; HUMAN; HUMAN CELL; ILLUMINATION; IN VITRO STUDY; PARTICLE SIZE; PHOTOSENSITIVITY; PHYSICAL CHEMISTRY; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; CHEMISTRY; COMPARATIVE STUDY; DRUG STABILITY; FIBROSARCOMA; PATHOLOGY; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FIBROSARCOMA; HUMANS; LIPIDS; NANOSTRUCTURES; PACLITAXEL; PARTICLE SIZE; TUMOR MICROENVIRONMENT; ULTRAVIOLET RAYS;

EID: 84910051150     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.940589     Document Type: Article

References (32)

1. Gullotti E, Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharmaceutics 2009; 6: 1041-51.
2. McNeeley K, Karathanasis E, Annapragada A, et al. Masking and triggered unmasking of targeting ligand on nanocarriers to improve drug delivery to brain tumors. Biomaterials 2009; 30: 3986-95.
3. Fang CL, Al-Suwayeh SA, Fang JY. Nanostructured lipid carriers (NLCs) for drug delivery and targeting. Recent Pat Nanotechnol 2013; 7: 41-55.
4. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63: 136-51.
5. Kesharwani P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials 2012; 33: 7138-50.
6. Ma DX, Shi NQ, Qi XR. Distinct transduction modes of arginimerich cell-penetrating peptides for cargo delivery into tumor cells. Int J Pharm 2011; 419: 200-8.
7. Vivès E, Schmidt J, Pèlegrin A. Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 2008; 1786: 126-38.
8. Kocer A, Walko M, Meijberg W, et al. A light-actuated nanovalve derived from a channel protein. Science 2005; 309: 755-8.
9. Chandra B, Subramaniam R, Mallik S, et al. Formulation of photocleavable liposomes and the mechanism of their content release. Org Biomol Chem 2006; 4: 1730-40.
10. Suzuki R, Oda Y, Utoguchi N, et al. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 2009; 133: 198-205.
11. Bartlett 2nd RL, Sharma S, Panitch A. Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants. Nanomedicine 2013; 9: 419-27.
12. Antipina MN, Sukhorukov GB. Remote control over guidance and release properties of composite polyelectrolyte based capsules. Adv Drug Delivery Rev 2011; 63: 716-29.
13. Elegbede AI, Banerjee J, Hanson AJ, et al. Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase- 9. J Am Chem Soc 2008; 130: 10633-42.
14. Davis SC, Szoka FC. Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. Bioconjugate Chem 1998; 9: 783-92.
15. Shi NQ, Gao W, Xiang B, et al. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage. Int J Nanomed 2012; 7: 1613-21.
16. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007; 9: E128-47.
17. Garde SV, Forte AJ, Ge M, et al. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD 13-expressing cells and its antitumor effects. AntiCancer Drugs 2007; 18: 1189-200.
18. Mayer G, Heckel A. Biologically active molecules with a "Light switch". Angew Chem Intl Ed 2006; 45: 4900-21.
19. Shamay Y, Adar L, Ashkenasy G, et al. Light induced drug delivery into cancer cells. Biomaterials 2011; 32: 1377-86.
20. Dadon Z, Samiappan M, Safranchik EY, et al. Light-induced peptide replication controls logic operations in small networks. Chem Eur J 2010; 16: 12096-9.
21. Hiraoka T, Hamachi I. Caged RNase: photoactivation of the enzyme from perfect off-state by site-specific incorporation of 2-nitrobenzyl moiety. Bioorg Med Chem Lett 2003; 13: 13-15.
22. Shirakawa I, Chaen S, Bagshaw CR, et al. Measurement of nucleotide exchange rate constants in single rabbit soleus myofibrils during shortening and lengthening using a fluorescent ATP analog. Biophys J 2000; 78: 918-26.
23. Goedhart J, Gadella Jr TW. Photolysis of caged phosphatidic acid induces flagellar excision in Chlamydomonas. Biochemistry 2004; 43: 4263-71.
24. Caldorera-Moore M, Guimard N, Shi L, et al. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 2010; 7: 479-95.
25. Fischer PM, Zhelev NZ, Wang S, et al. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 2000; 55: 163-72.
26. Gao W, Xiang B, Meng TT, et al. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials 2013; 34: 4137-49.
27. Zhang P, Ling G, Pan X, et al. Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride. Nanomedicine 2012; 8: 185-93.
28. Haycock JW. 3D cell culture: a review of current approaches and techniques. Methods Mol Biol 2011; 695: 1-15.
29. Allen TM, Hansen C, Martin F, et al. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29-36.
30. Zhang QY, Tang J, Ling F, et al. A pH-responsive a-helical cell penetrating peptide-mediated liposomal delivery system. Biomaterials 2013; 34: 7980-93.
31. Nakase I, Akita H, Kogure K, et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc Chem Res 2012; 45: 1132-9.
32. Mehta G, Hsiao AY, Ingram M, et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release 2012; 164: 192-4.